March 23, 2017/Cancer/News & Insight

New Cancer Center Houses Ohio’s Most Advanced Gamma Knife Technology

Icon one of many upgrades in new building

suh-icon_650x450

The new Taussig Cancer Center building, which opened March 6, 2017, houses Ohio’s first Leksell Gamma Knife Icon™ radiosurgery technology. Icon offers the most precise brain radiosurgery capabilities of any currently available technology.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The addition of this new technology further enhances patient care, research and education at Cleveland Clinic Cancer Center. Since 1997, the center has performed over 6000 cases using Gamma Knife for brain tumor treatment. Cleveland Clinic is also one of the few centers to offer a week-long Gamma Knife training course, which has trained hundreds of physicians and medical physicists. In addition, the center is active in scientific and clinical research, has ongoing clinical trials for patients with brain metastases and holds an annual international symposium on radiosurgery.

Upgraded features benefit patient care

Icon’s front-mounted, cone-beam CT scanner allows the physician to verify the patient’s head position prior to treatment. This verification enables physicians to treat tumors in locations close to critical structures such as the optic apparatus and brain stem, and to replace rigid frames that screw into a patient’s skull with a mask as a stereotactic reference.

The mask “offers a better patient experience for some patients and allows us to divide treatments over multiple sessions, which is useful for some complex cases,” says John Suh, MD, Chair of the Department of Radiation Oncology at Cleveland Clinic’s Taussig Cancer Center and Associate Director of the Gamma Knife Center. The presence of high-definition motion management, which uses an infrared camera, monitors any patient motion during treatment.

Advertisement

Icon one of many upgrades in new building

The new 377,000-square-foot, $276 million Cancer Center building is designed, top to bottom, to “optimize multidisciplinary care and patient experience and minimize wait times,” says Dr. Suh. The light-filled building extends its brightness to the lower level of the radiation treatment center with an enormous standing skylight that protrudes into the parking drop off area. “The presence of natural light into the radiation oncology department is very important. It helps make the space more open and inviting, which helps comfort patients and their families,” says Dr. Suh.

All radiation treatments will occur in the new Cancer Center. Six state-of-the-art linear accelerators with image guidance, two large bore CT simulators, a hyperthermia suite, a high-dose rate brachytherapy suite and MRI for simulation will join Icon in the array of radiation treatments available for Cleveland Clinic patients. In addition, the lower level will feature a large physician conference room with two 100-inch monitors.

“It’s a very exciting time in oncology, in particular radiation oncology,” says Dr. Suh. “We plan to create the future of cancer care in the new Taussig Cancer Center by providing timely, compassionate, innovative and comprehensive cancer care.”

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad